Key result
Endothelial dysfunction severity is linked to CV risk, offering a potential surrogate marker for atherosclerosis.
Why the study?
Defining new approaches for the prevention and treatment of atherosclerosis is a priority, and evaluating the current clinical utility of endothelial dysfunction as a patient care tool or surrogate marker is needed.
Answers are grounded in this paper and cite their sources.
Endothelial dysfunction serves as a marker of cardiovascular risk and may be useful as a surrogate marker for evaluating new therapeutic strategies.
Defining new approaches for the prevention and treatment of atherosclerosis is an important priority. Recently, measurement of endothelial function in patients has emerged as a useful tool for atherosclerosis research. Risk factors are associated with impaired endothelial function, and clinical syndromes relate, in part, to a loss of endothelial control of vascular homeostasis. Recent studies have shown that the severity of endothelial dysfunction relates to cardiovascular risk. A growing number of interventions known to reduce cardiovascular risk have been shown to improve endothelial function. This work suggests that studies of endothelial function could be used in the care of patients and as a surrogate marker for the evaluation of new therapeutic strategies. This article will review this growing literature in an effort to evaluate the current clinical utility of endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Widlansky et al. (2003) conducted a review in Atherosclerosis. Endothelial function measurement was evaluated. Endothelial dysfunction severity relates to cardiovascular risk, suggesting its measurement could serve as a surrogate marker for evaluating new therapeutic strategies in atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: